Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313390657> ?p ?o ?g. }
- W4313390657 endingPage "490" @default.
- W4313390657 startingPage "483" @default.
- W4313390657 abstract "Chiral metallic drugs are becoming the hottest point of discussion in the field of medicinal chemistry. As we know that more than 80% drugs are chiral in nature, and prescribed in the racemic form. The main problem with chiral drugs is the different biological activities of different enantiomers. This is because the human body has a chiral environment, as there is the presence of protein, carbohydrates, enzymes, and other chiral macromolecules. Hence, if a chiral anticancer drug is being prescribed to the patient in the racemic form, it means two or more drugs are being prescribed. Therefore, the chiral separation and analysis of chiral anticancer drugs are important for improving the quality of chiral drug medication. Many metal complexes are used as anticancer drugs, but the conditions become more critical if they have chirality or a chiral moiety, because of which they exist in two or more forms. Because of the presence of chirality or chiral moiety, the complex of metals is termed a chiral metallic complex. Of course, the enantioseparation of the chiral metallic complexes must be done before their prescription. Enantioseparation of the chiral metallic complex will not only provide a pharmaceutically active form to the patient but also reduce the side effects caused by the racemic mixture. Hence, the accessible article reviews the chiral metallic complexes having ruthenium, osmium, palladium, gold, silver, and platinum, etc. as central metal atoms. Besides, the future perspectives regarding the chiral metallic anticancer drugs and the role of their enantioseparation are also discussed." @default.
- W4313390657 created "2023-01-06" @default.
- W4313390657 creator A5028362620 @default.
- W4313390657 creator A5054236996 @default.
- W4313390657 date "2022-12-31" @default.
- W4313390657 modified "2023-10-01" @default.
- W4313390657 title "Chiral metallic anticancer drugs: A brief-review" @default.
- W4313390657 cites W1963988724 @default.
- W4313390657 cites W1969240534 @default.
- W4313390657 cites W1977443601 @default.
- W4313390657 cites W1989943214 @default.
- W4313390657 cites W1991998089 @default.
- W4313390657 cites W1994438706 @default.
- W4313390657 cites W2001928738 @default.
- W4313390657 cites W2017356685 @default.
- W4313390657 cites W2022751983 @default.
- W4313390657 cites W2027892834 @default.
- W4313390657 cites W2036105878 @default.
- W4313390657 cites W2045329873 @default.
- W4313390657 cites W2045671967 @default.
- W4313390657 cites W2046654869 @default.
- W4313390657 cites W2050691984 @default.
- W4313390657 cites W2051134553 @default.
- W4313390657 cites W2052002840 @default.
- W4313390657 cites W2056659360 @default.
- W4313390657 cites W2076802369 @default.
- W4313390657 cites W2093546262 @default.
- W4313390657 cites W2093642927 @default.
- W4313390657 cites W2111865926 @default.
- W4313390657 cites W2112253518 @default.
- W4313390657 cites W2119730164 @default.
- W4313390657 cites W2130177169 @default.
- W4313390657 cites W2137773467 @default.
- W4313390657 cites W2150857235 @default.
- W4313390657 cites W2155427922 @default.
- W4313390657 cites W2282989227 @default.
- W4313390657 cites W2300701790 @default.
- W4313390657 cites W2312696954 @default.
- W4313390657 cites W2323951910 @default.
- W4313390657 cites W2331461295 @default.
- W4313390657 cites W2331733724 @default.
- W4313390657 cites W2365503837 @default.
- W4313390657 cites W2499475344 @default.
- W4313390657 cites W2559999038 @default.
- W4313390657 cites W2573140481 @default.
- W4313390657 cites W2578784145 @default.
- W4313390657 cites W2588423120 @default.
- W4313390657 cites W2605474943 @default.
- W4313390657 cites W2614437752 @default.
- W4313390657 cites W2625960443 @default.
- W4313390657 cites W2734647920 @default.
- W4313390657 cites W274446343 @default.
- W4313390657 cites W2767083249 @default.
- W4313390657 cites W2770473333 @default.
- W4313390657 cites W2783576278 @default.
- W4313390657 cites W2787244696 @default.
- W4313390657 cites W2788218532 @default.
- W4313390657 cites W2791851526 @default.
- W4313390657 cites W2801859295 @default.
- W4313390657 cites W2884803887 @default.
- W4313390657 cites W2884946808 @default.
- W4313390657 cites W2895828417 @default.
- W4313390657 cites W2897542015 @default.
- W4313390657 cites W2905746144 @default.
- W4313390657 cites W2907210047 @default.
- W4313390657 cites W2921851486 @default.
- W4313390657 cites W2927283616 @default.
- W4313390657 cites W2970150149 @default.
- W4313390657 cites W2981071026 @default.
- W4313390657 cites W2981936976 @default.
- W4313390657 cites W3037122783 @default.
- W4313390657 cites W3049575158 @default.
- W4313390657 cites W3119395809 @default.
- W4313390657 cites W3125982819 @default.
- W4313390657 cites W3173071079 @default.
- W4313390657 cites W3189765419 @default.
- W4313390657 cites W4205475325 @default.
- W4313390657 cites W4221005291 @default.
- W4313390657 cites W4225738385 @default.
- W4313390657 cites W4252355306 @default.
- W4313390657 cites W4281629898 @default.
- W4313390657 cites W2010690765 @default.
- W4313390657 doi "https://doi.org/10.5155/eurjchem.13.4.483-490.2312" @default.
- W4313390657 hasPublicationYear "2022" @default.
- W4313390657 type Work @default.
- W4313390657 citedByCount "1" @default.
- W4313390657 countsByYear W43133906572023 @default.
- W4313390657 crossrefType "journal-article" @default.
- W4313390657 hasAuthorship W4313390657A5028362620 @default.
- W4313390657 hasAuthorship W4313390657A5054236996 @default.
- W4313390657 hasBestOaLocation W43133906571 @default.
- W4313390657 hasConcept C121332964 @default.
- W4313390657 hasConcept C124668440 @default.
- W4313390657 hasConcept C146686406 @default.
- W4313390657 hasConcept C161790260 @default.
- W4313390657 hasConcept C163845019 @default.
- W4313390657 hasConcept C16838498 @default.
- W4313390657 hasConcept C178790620 @default.